All In MedTech

Device Trial Radar · NCT07354945

An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children

An Evaluation of Visual Comfort, Adaptation and Overall Satisfaction in Myopic Children Using A.M.L. Series of Lenses

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

40

Actual

Start

Jan 2, 2026

Primary completion

Mar 7, 2026

Study completion Jun 27, 2027

Sponsor

Lead sponsor
Essilor InternationalNot on our public-company list
Sponsor type
Industry
First posted
Jan 21, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 6 years, up to 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this research study is to understand the wearing experience of A.M.L. series of lenses in myopic children. The main questions it aims to answer are: * How quickly and effectively children adapt to the A.M.L. series of lenses? * How do children perceive the short-term and long-term visual comfort and satisfaction of A.M.L. series lenses? * How effective is A.M.L. series of lenses in slowing down the myopia progression in children? 40 myopic children aged 6 to 12 years will be recruited as participants, and all of them will be wearing A.M.L. series of lenses. Participants will: * Wear A.M.L. series of lenses for a period of 1 year. * Visit at Screening, Baseline, 4 days, 1 week, 2 weeks, 6 months and 12 months.

Conditions

  • Myopia
  • Refractive Error
  • Myopia Progression

Interventions

  • A.M.L. Series of LensesDevice

    Participants will be wearing A.M.L. series of lenses for a period of 1 year.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The proportion of children who adapted to the study lenses within 4-6 days without reporting any symptoms.Time frame: 6 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Shanghai Meishimeijing Ophthalmology Clinic Co., Ltd.

    Shanghai, Shanghai Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.